< href=http://rxbuywithoutprescriptiononline.net/propecia.html>Propecia no prescription < href=http://rxbuywithoutprescriptiononline.org/lasix.html>lasix buy Sertraline online < href=http://rxnoprescriptionbuyonlinerx.net>Accutane without prescription buy trazodone online buy Zyban without prescription < href=http://rxbuyonlinewithoutprescription.net/zetia.html>zetia without prescription < href=http://rxbuywithoutprescriptiononline.net/clomid.html>Clomid Without Prescription < href=http://rxbuywithoutprescriptiononline.org/ventolin.html>buy ventolin < href=http://rxnoprescriptionbuyonline.com/strattera.html>buy Strattera < href=http://rxbuyonlinewithoutprescriptionrx.net/valtrex.html>buy Valtrex online < href=http://rxbuywithoutprescriptiononline.net/zithromax.html>buy Zithromax without prescription
portfolio

Sanifit

Sanifit is a clinical-stage biopharmaceutical company focused on the development of SNF472, an experimental drug for the treatment of cardiovascular diseases linked to calcification in the End Stage Renal Disease population undergoing haemodialysis.
 
 
Sanifit_logo Portfolio Ysios Capital
 

Details
Laboratoris Sanifit
Parc Bit
Building Naorte – PB4
Palma de Mallorca,07121
Spain
www.sanifit.com

 
Sanifit news

06.08.18
Sanifit announces completion of enrollment in CaLIPSO – its Phase 2b Study for the Treatment of Cardiovascular Calcification in End-Stage-Renal-Disease Patients on Haemodialsis

06.03.18
Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis

08.01.18
Sanifit announces the appointment of Cris Calsada as Chief Financial Officer

Read more
This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. For more information on cookies check http://www.ysioscapital.com/legal-notice/ I agree